Provencio M, Serna-Blasco R, Nadal E, Insa A, et al. Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial). J Clin Oncol 2022 May 16:JCO2102660. doi: 10.1200/JCO.21.02660.
PMID: 35576508